Home
We are currently focusing our efforts to develop ZFP-Therapeutics for the following conditions:
Diabetic Neuropathy
  Phase 1 Clinical Trial
  Phase 2 Clinical Trial
Cardiovascular and Peripheral Artery Disease
Cancer
Neuropathic Pain
HIV/AIDS
Congestive Heart Failure
Monogenic Diseases

  VEGF is a potent stimulator of blood vessel formation, or angiogenesis, but to grow healthy, non-leaky vessels, all of the forms of the VEGF protein must be present. That's where ZFP TFs will make a difference...
more

Another application of our technology is the development of ZFP nucleases (ZFN™) to correct the DNA sequence of a gene containing a disease-related mutation or disrupt the sequence of a gene that facilitates disease.
Contact Careers Site Map Legal Glossary